OpenAI researcher Miles Wang departs to launch $2B AI drug discovery startup
Seeking Alpha ·
OpenAI ( OPENAI ) researcher Miles Wang is leaving the ChatGPT maker to launch a new startup focused on developing AI models for drug discovery, Tech Crunch reported, citing sources familiar with the matter. Several other OpenAI (
DYAX Investor Sentiment
Bullish (Long) 45% · Bearish (Short) 55%
444 participants
Related News
- Pentair falls 14% as pool inventory issues force guidance cut, CFO exits
- Rocket Lab tests 200-day average, Schaeffer's sees bullish signal
- Copa Holdings June passenger traffic: Capacity jumps 16.4%, load factor eases to 85.2%
- SK Hynix ADR options debut sees heavy activity in July 17 expiry
- Citi to boost planned Q3 dividend by 12% and launches $30B share buyback
- NVIDIA (NVDA) CEO Huang says Vera Rubin is on track, already in production